Clariant has spent the last few years realigning its specialty chemicals portfolio and is mostly finished with the process, although it will continue to keep an eye on commoditization and other trends, says CEO Conrad Keijzer. "We invest in innovation, we make sure that the specialty businesses we have stay specialty, and we don't see any special announcements or divestments in the near future," says Keijzer.